Identification of 5 genes involved in the metastasis of breast tumors to the lung

	Tweet

The identification of five genes involve in the metastasis of breast tumours to the lung is the principal finding of a scientific team made up of two bodies from the University of Navarra, the Applied Medical Research Centre (CIMA) and the University Hospital of the University of Navarra.

Doctor Alfonso Calvo, researcher in the area of Oncology at the CIMA, led the work with the special collaboration of Doctor Ignacio Gil Bazo, cancer specialist from the University Hospital. The study made up a significant part of Mr Raúl Catena’s PhD thesis.

For this research, recently published in the scientific journal Oncogene, a transgenic mouse model which presented a greater tendency for developing metastasis was employed. 

The increase in what is known as the Vascular Endothelial Growth Factor (VEGF) in its mammary glands triggered profound changes in the tumoural structure, which enabled the malignant cells to leave the tumour and invade the lungs.

Finally, the pattern of genes responsible for this tumoural migration to the lungs was analysed and this was compared to that shown by women with breast tumours with pulmonary metastatic affectation. It was shown that five of these genes were common to the animal model and patients with breast cancer.
Most effective ways of treatment

According to the results of this study, of the five genes identified, the Tenascina-C gene seems to be a good therapeutic target for the treatment of metastatic breast cancer. In fact, the blocking of the expression of this gene in the animal model enabled a significant reduction, both in tumour growth and in the incidence of pulmonary metastasis.

This new discovery in the complex network that is the metastasis process of tumours provides key data on the knowledge of cancer and its spreading, at the same time identifying new targets for which new pharmaceutical medicines that contribute to more efficacious treatment of this disease can be designed.

References
Calvo A, Catena R, Noble MS, Carbott D, Gil-Bazo I, Gonzalez-Moreno O, Huh JI, Sharp R, Qiu TH, Anver MR, Merlino G, Dickson RB, Johnson MD, Green JE. Identification of VEGF-regulated genes associated with increased lung metastatic potential: functional involvement of tenascin-C in tumor growth and lung metastasis. Oncogene. 2008 May 26

Contact:
Jesús Zorrilla Ruiz
Clínica Universitaria. Universidad de Navarra

Contact details:

(+34) 948-296.497 / 948-255.400

RELATED STORIES:
Iressa Shows Promise For Treatment of Metastatic Breast Cancer When Combined With Hormonal Therapy   Investigational Treatment Shows Promise in Metastatic Breast Cancer   Vitamin D and breast cancer risk   Hispanic Women Have Higher Incidence of Rare Breast Tumor   Women advised to avoid ZEN bust-enhancing supplements because of possible cancer risk   More women with early-stage breast cancer choosing double mastectomies   Fish Oil May Reduce Risk of Breast Cancer   UB played major role in study on drug that reduces breast cancer in high-risk women   What Breast Cancer Patients Don’t Know About Mastectomy Options Can Cause Lifelong Disfigurement   Intake of Vitamin D, Calcium Associated With Lower Risk of Breast Cancer Before Menopause   New Dubin Breast Center at Mount Sinai Raises the Standard for Comprehensive Cancer Care   3-week course of breast radiation may be as effective as conventional 5- to 7-week course   Breast Tenderness During HRT Linked to Elevated Cancer Risk   Breast cancer risk after false-positive mammography results   Exercise reduces fatigue after breast cancer   Gene Helps Protect Tumor Suppressor in Breast Cancer   Many breast cancer patients take high doses of antioxidants despite possible consequences   Red Or White Wine? Both Are Equal in Terms of Breast-Cancer Risk   How women can improve their quality of life after breast cancer treatment   Use of costly breast cancer therapy strongly influenced by reimbursement policy   Drug Combo Shrinks Breast Cancer Metastases in Brain   Breast Density Linked to Increased Cancer Recurrence Risk

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]